Groowe BETA / Newsroom

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041

businesswire.com July 30, 2026 at 7:05 AM ET

SVRA The granting of patents for MOLBREEVI* in Europe and Australia until March 2041 strengthens Savara's intellectual property position and market exclusivity, indicating positive future prospects for the company.